rs886041078
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_005506.4(SCARB2):c.1270C>T(p.Arg424*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000682 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005506.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCARB2 | NM_005506.4 | c.1270C>T | p.Arg424* | stop_gained | Exon 11 of 12 | ENST00000264896.8 | NP_005497.1 | |
SCARB2 | NM_001204255.2 | c.841C>T | p.Arg281* | stop_gained | Exon 8 of 9 | NP_001191184.1 | ||
SCARB2 | XM_047416429.1 | c.796C>T | p.Arg266* | stop_gained | Exon 11 of 12 | XP_047272385.1 | ||
SCARB2 | XM_047416430.1 | c.796C>T | p.Arg266* | stop_gained | Exon 11 of 12 | XP_047272386.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251444Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135898
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461878Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727236
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152162Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74308
ClinVar
Submissions by phenotype
Action myoclonus-renal failure syndrome Pathogenic:1Other:1
- -
- -
Inborn genetic diseases Pathogenic:1
The p.R424* pathogenic mutation (also known as c.1270C>T), located in coding exon 11 of the SCARB2 gene, results from a C to T substitution at nucleotide position 1270. This changes the amino acid from an arginine to a stop codon within coding exon 11. This variant was detected in the homozygous state in an individual with unsteady gait, myoclonus, tremors, seizures; both parents were confirmed carriers (Zeigler M et al. J. Neurol. Sci., 2014 Apr;339:210-3). In another family, this mutation was detected in the homozygous state in two similarly affected siblings with gait disorder, and tremor; one sibling had seizures and a paternally inherited variant in KCNQ2, which was absent from the second sibling (He M et al. Clin. Genet., 2014 Dec;86:598-600). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Progressive myoclonic epilepsy Pathogenic:1
This premature translational stop signal has been observed in individuals with progressive myoclonic epilepsy (PMID: 24485911, 24620919). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg424*) in the SCARB2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCARB2 are known to be pathogenic (PMID: 19847901). ClinVar contains an entry for this variant (Variation ID: 268146). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at